DF Deutsche Forfait AG

  • WKN: A2AA20
  • ISIN: DE000A2AA204
  • Land: Deutschland

Nachricht vom 29.06.2021 | 15:13

​​​​​​​DF Deutsche Forfait AG continues to make operational progress

DGAP-News: DF Deutsche Forfait AG / Key word(s): AGM/EGM
29.06.2021 / 15:13
The issuer is solely responsible for the content of this announcement.

Annual General Meeting 2021
DF Deutsche Forfait AG continues to make operational progress

  • Full-year targets 2020 achieved
  • Corporate purpose of DF Group is expanded
  • Forecast for the current fiscal year confirmed

Grünwald, 29 June 2021 - At the Annual General Meeting of DF Deutsche Forfait AG (ISIN DE000A1R1CC4), which was once again held virtually due to the COVID-19 pandemic, the Management Board and the Supervisory Board informed the company's shareholders about the past financial year 2020. Accordingly, the Group was again able to achieve its targets in the reporting period.

All resolutions proposed by the Company were approved by a clear majority at the Annual General Meeting. The agenda items to be voted on included the re-election of the auditing firm Warth & Klein Grant Thornton AG as auditors, the approval of the remuneration system for the Management Board, and the expansion of the Company's corporate purpose.

In addition to the operational development in the 2020 financial year, the Management Board explained the strategic orientation and confirmed the forecast for the current financial year. "We are pleased with the trust that the shareholders have once again placed in us. As announced, we are continuously expanding our existing business by offering more extensive advisory and brokerage services. The expansion of the Company's corporate purpose provides us with the greatest possible flexibility in this regard," said CEO Dr. Behrooz Abdolvand in his address to the shareholders.

The detailed voting results are available on the Company's website at https://www.dfag.de/en/investor-relations/annual-general-meeting/.
 

About DF Group

DF Group is a global specialist in foreign trade financing with a focus on the Middle East and Eastern Europe. DF Deutsche Forfait focuses on food, pharmaceutical, healthcare, industrial companies, energy and infrastructure sectors. With its extensive financial experience, its distinctive network and its comprehensive compliance expertise, DF Group offers exporters, importers, industrial companies, banks and financial service providers the right financing solution.

 

Contact:
DF Deutsche Forfait AG
Nördliche Münchner Straße 9c
82031 Grünwald
T +49 89 21551900-0
F +49 89 21551900-9
E investor.relations@dfag.de
http://www.dfag.de


Investor Relations / Press:
Stefanie Eberding
T +49 221 9737661
E investor.relations@dfag.de



29.06.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Symrise verlängert Vorstandsvertrag von Dr. Heinz-Jürgen Bertram vorzeitig bis 2025

01. Dezember 2021, 15:38

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

Bio-Gate AG

Original-Research: Bio-Gate AG (von GBC AG): Kaufen

02. Dezember 2021